EarliPoint Health Launches Skill Illustrator™ to Help Providers Translate Assessment Data into Actionable Developmental Insights.

Read Release →

EarliPoint Health Launches Skill Illustrator™ to Help Providers Translate Assessment Data into Actionable Developmental Insights

On This Page

New feature advances EarliPoint’s vision of delivering objective intelligence across the autism care journey

PLYMOUTH, MN — June 16, 2026 — EarliPoint Health today announced the launch of Skill Illustrator™, an innovative new feature that helps providers transform objective developmental assessment data into actionable skill-based insights that can support treatment planning, progress monitoring, and family engagement.

Built upon EarliPoint’s FDA-cleared eye-tracking technology, Skill Illustrator translates a child’s developmental profile into clinically meaningful skill areas, helping providers better understand developmental strengths and opportunities while connecting assessment results to real-world care decisions.

The launch represents the next step in EarliPoint’s evolution from an objective developmental assessment platform to a broader source of clinical intelligence for autism care.

“Providers are increasingly being asked to demonstrate measurable progress and deliver more personalized care, yet many of the tools available today stop at identifying developmental differences,” said Cheryl Tierney, MD, Chief Medical Officer of EarliPoint Health. “Skill Illustrator helps bridge the gap between assessment and intervention by translating objective developmental measurement into meaningful skill-based insights that clinicians can use to guide care, communicate with families, and support ongoing treatment planning.”

For decades, autism care has relied heavily on subjective observation and episodic assessments to evaluate developmental progress. While these approaches remain important, providers, families, and payers are increasingly seeking objective tools that can support more consistent measurement and greater transparency across the care journey.

Skill Illustrator expands the clinical utility of EarliPoint by helping providers move beyond understanding where a child is today and toward identifying developmental areas that may benefit from focused support and intervention.

“Our vision has always been to impact the entire care journey,” said Jamie Pagliaro, President and CEO of EarliPoint Health. “While EarliPoint began by bringing objective measurement to developmental assessment, we believe the future of autism care requires objective insights that extend beyond assessment alone. Providers need better tools to inform care, measure progress, communicate outcomes, and support more individualized treatment decisions. Skill Illustrator represents an important step in our evolution toward delivering objective intelligence for autism care.”

Skill Illustrator complements existing clinical assessment and treatment planning frameworks while providing providers with a new way to leverage objective developmental measurement throughout the care continuum. The feature is designed to support a wide range of use cases, including developmental assessment, treatment planning, reassessment, progress monitoring, and communication with families and payers.

The introduction of Skill Illustrator reflects EarliPoint Health’s broader mission to create a common source of truth across autism care. By combining objective developmental measurement with actionable clinical insights, EarliPoint aims to help providers improve transparency, strengthen accountability, and better understand outcomes over time.

As healthcare increasingly shifts toward value-based care and measurable outcomes, objective data will play an increasingly important role in how autism services are delivered, evaluated, and reimbursed. EarliPoint believes that objective developmental measurement, longitudinal tracking, and actionable insights will form the foundation of the next generation of autism care.

About EarliPoint Health

EarliPoint Health delivers FDA-cleared eye-tracking biomarkers that support objective autism diagnosis, developmental assessment, and longitudinal measurement. Through a brief, non-intrusive assessment experience, EarliPoint provides objective insights across social engagement, language, and cognition, helping providers establish developmental baselines, inform care decisions, and measure progress over time. EarliPoint Health’s vision is to deliver objective intelligence for autism care, creating a common source of truth that supports earlier answers, measurable progress, and improved transparency across the care journey.

Pete Polgar

VP of Marketing

Pete Polgar is the Vice President of Marketing at Earlipoint. He leads the company’s marketing strategy, focusing on brand positioning, demand generation, and digital growth. With a background in performance marketing and content strategy, Pete works on aligning marketing initiatives with business development to drive measurable results and expand Earlipoint’s market presence.

Pete Polgar

VP of Marketing

Pete leads EarliPoint’s marketing strategy — driving brand growth, demand generation, and measurable business results.

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder